Immunovia AB (publ)
F:1YR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Immunovia AB (publ)
F:1YR
|
SE |
|
Integrated Rail and Resources Acquisition Corp
OTC:IRRX
|
US |
|
IGEN Networks Corp
OTC:IGEN
|
US |
|
Nexus Uranium Corp
OTC:NEXUF
|
CA |
|
A
|
Acom Co Ltd
F:AK5
|
JP |
|
W
|
WeGrow AG
DUS:ZN2
|
DE |
|
C
|
Chinyang Chemical Corp
KRX:051630
|
KR |
|
Basf Se
MIL:1BAS
|
DE |
|
L
|
Laredo Petroleum Inc
F:8LP1
|
US |
|
E
|
EON Resources Inc
AMEX:EONR
|
US |
|
Ibc Advanced Alloys Corp
XTSX:IB
|
US |
|
S
|
Sungwoo Electronics Co Ltd
KOSDAQ:081580
|
KR |
|
Mcf Energy Ltd
XTSX:MCF
|
CA |
|
Bioxytran Inc
OTC:BIXT
|
US |
|
Goldrich Mining Co
OTC:GRMC
|
US |
Wall Street
Price Targets
1YR Price Targets Summary
Immunovia AB (publ)
According to Wall Street analysts, the average 1-year price target for
1YR
is 0.0004 EUR
with a low forecast of 0.0004 EUR and a high forecast of 0.0004 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is 1YR's stock price target?
Price Target
0.0004
EUR
According to Wall Street analysts, the average 1-year price target for
1YR
is 0.0004 EUR
with a low forecast of 0.0004 EUR and a high forecast of 0.0004 EUR.
What is Immunovia AB (publ)'s Revenue forecast?
Projected CAGR
330%
For the last 11 years the
compound annual growth rate for
Immunovia AB (publ)'s revenue is
6%.
The projected
CAGR
for the next 3 years is
330%.
